Depression Predicts Cannabis Initiation in Mexican American Young Adults

Among 616 cannabis-naïve Mexican American college students, higher depressive symptoms predicted starting cannabis use one year later—supporting the self-medication hypothesis in an understudied population.

Arora, Srishty et al.·Substance use & misuse·2026·Moderate EvidenceLongitudinal Cohort·1 min read
RTHC-08090Longitudinal CohortModerate Evidence2026RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Longitudinal Cohort
Evidence
Moderate Evidence
Sample
N=616
Participants
N=616 cannabis-naïve Mexican American college students aged 18-29, Texas.

What This Study Found

The question of whether depression leads to cannabis use or cannabis leads to depression has been debated for decades. This study provides evidence for the former: depressive symptoms came first, and cannabis initiation followed.

The researchers tracked 616 Mexican American college students in Texas (ages 18–29) who had never used cannabis at baseline. One year later, those with higher depressive symptoms were significantly more likely to have initiated cannabis use. This prospective design—measuring depression before cannabis use begins—is stronger than cross-sectional studies that measure both at the same time and can't determine direction.

The study also tested whether family factors moderated this relationship. Neither family cohesion (closeness, support) nor family conflict buffered or worsened the depression-to-cannabis pathway. This was somewhat surprising given the cultural emphasis on family (familismo) in Mexican American communities—the expectation was that strong family bonds might protect against self-medication.

The null family finding suggests that the depression-cannabis link operates relatively independently of family dynamics in this population—it's not that bad family relationships push depressed young people toward cannabis, or that good family relationships protect against it. The individual's emotional state appears to be the primary driver.

Key Numbers

N = 616 cannabis-naïve Mexican American college students. Ages 18–29. Greater depressive symptoms predicted cannabis initiation at 1 year. Family cohesion and family conflict did not moderate the association.

How They Did This

Longitudinal cohort study. 616 cannabis-naïve Mexican American college students ages 18–29 in Texas. Depressive symptoms, family cohesion, and family conflict assessed at baseline. Cannabis initiation assessed one year later. Mixed-effects logistic regression.

Why This Research Matters

Hispanic/Latino young adults are the fastest-growing demographic in U.S. colleges, yet their cannabis initiation patterns are understudied. Understanding that depression drives cannabis uptake in this population—and that family factors don't buffer it—has implications for prevention: campus mental health services may be more effective than family-based interventions for reducing cannabis initiation.

The Bigger Picture

This adds population-specific evidence to the self-medication hypothesis. RTHC-00192 found that pain drove cancer survivors toward cannabis (and away from alcohol). RTHC-00157 documented the PTSD-cannabis self-medication cycle. This study extends the pattern to depression in a specific ethnic group, showing that emotional distress precedes cannabis use rather than following it—at least for initial use.

What This Study Doesn't Tell Us

Self-reported depressive symptoms and cannabis use. College students at one Texas institution may not represent all Mexican American young adults. One-year follow-up is relatively short. The study measured cannabis initiation (any use), not progression to regular use or disorder. Cultural context (South Texas, predominantly Catholic) may limit generalizability to other Hispanic populations. Family measures were at a single timepoint.

Questions This Raises

  • ?Does the depression-cannabis link persist in other Hispanic/Latino populations?
  • ?Would treating depression reduce cannabis initiation rates in this group?
  • ?Do those who initiate cannabis for depression continue using it, and does it help or worsen their depressive symptoms long-term?

Trust & Context

Key Stat:
Evidence Grade:
Prospective longitudinal design in a specific population—stronger than cross-sectional for establishing temporal direction, though still observational.
Study Age:
Published in 2026 with data from Mexican American college students in Texas.
Original Title:
Depressive Symptoms Predict Cannabis Initiation Among Mexican American Young Adults.
Published In:
Substance use & misuse, 1-10 (2026)Substance Use & Misuse is a peer-reviewed journal focusing on research related to substance use and its effects.
Database ID:
RTHC-08090

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-ControlFollows or compares groups over time
This study
Cross-Sectional / Observational
Case Report / Animal Study

Follows a group of people over time to track how outcomes develop.

What do these levels mean? →

Read More on RethinkTHC

Cite This Study

RTHC-08090·https://rethinkthc.com/research/RTHC-08090

APA

Arora, Srishty; North, Caroline; Marti, C Nathan; Schwartz, Seth J; Bataineh, Bara S; Talavera-Garza, Liza; Loukas, Alexandra; Wilkinson, Anna V. (2026). Depressive Symptoms Predict Cannabis Initiation Among Mexican American Young Adults.. Substance use & misuse, 1-10. https://doi.org/10.1080/10826084.2026.2631797

MLA

Arora, Srishty, et al. "Depressive Symptoms Predict Cannabis Initiation Among Mexican American Young Adults.." Substance use & misuse, 2026. https://doi.org/10.1080/10826084.2026.2631797

RethinkTHC

RethinkTHC Research Database. "Depressive Symptoms Predict Cannabis Initiation Among Mexica..." RTHC-08090. Retrieved from https://rethinkthc.com/research/arora-2026-depressive-symptoms-predict-cannabis

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.